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Figure 1 Somatostatin Receptor Subtype-2–based PET/CT Imaging of Atherosclerosis
(A) Whole-body imaging by 68Gallium-[1,4,7,10-tetraazacyclododecane-N,N0,N,N0 -tetraacetic acid]-D-Phe1,Tyr3-octreotate (68Ga-DOTATATE) positron emission tomography/
computed tomography (PET/CT) of a patient with metastatic neuroendocrine tumor. Maximum intensity projection (left) shows DOTATATE biodistribution. Transaxial
fused PET/CT scan (right; full image and magniﬁcation) at the location of the lower kidneys shows plaque, with focal uptake in the abdominal aorta, partially calciﬁed on the
CT scan. (B) Regression plot for DOTATATE overall vessel uptake (OVU) index and patient age at the time of scan 1. (C) Group results of OVU at the time of 3 scans (red
bar indicates timing of peptide receptor radionuclide therapy [PRRT]). (D) Representative example of a calciﬁed and initially DOTATATE-avid aortic arch plaque showing stable
target-to-background ratio (TBR) between scans 1 and 2. It declined after PRRT.
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2013;54:855–60.Letters to the EditorDiagnosis of “Paradoxical” Low-
Gradient Aortic Stenosis PatientsThe report by Lauten et al. (1) investigates a very important clinical
presentationd“paradoxical” low-gradient aortic stenosis (PLG AS).
This is a diagnostic challenge, and their work deﬁnitely improves our
understanding of this problem. However, we found multiple
inconsistencies and unclear explanations that we wish to highlight.
First, the authors compared echocardiographic and catheteri-
zation data in PLG AS to evaluate errors and bias of echocar-
diography measurements. Unfortunately, this inherently assumes
that catheterization measurements represent a veritable “gold-
standard” measurement. Cardiac catheterization has inherent
errors and uncertainties, including uncertainty in measuring stroke
volume, errors in pressure measurements, and assumption of
identical hemodynamic conditions between catheterization and
echocardiography. A bench-top in vitro study might provide
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2346better control to test this hypothesis. Signiﬁcantly, the authors
used the “pullback” technique of assessing transvalvular gradient
(DP), which is inaccurate in atrial ﬁbrillation (approximately 20%
of patients in the “paradoxical” group); and even in sinus rhythm,
there is signiﬁcant motion artifact and sometimes “drift” in the
pressure.
Second, measurements obtained from invasive catheterization
and echocardiography are fundamentally different due to pressure
recovery. Although echocardiography measures the distal pressure
at the jet vena contracta, catheterization always measures a higher
aortic pressure due to pressure recovery, as shown by multiple
clinical and in vitro studies (2–4). This can explain some of the
discrepancy in measurements from these 2 methods.
Third, the authors discuss how their ﬁndings contradict the
ﬁndings of Hachicha et al. (5), potentially due to patient selection
criteria, which is puzzling. This study suggests that the “paradox-
ical” group had functionally less severe AS, whereas clinical studies
have shown that these patients have the worst prognosis (6,7). We
do not suggest that 1 method of patient selection is superior to
another; however, this raises an interesting question about whether
the deﬁnition of PLG AS must be clariﬁed from a patient selection
standpoint.
Fourth, the comparison of Gorlin and continuity equations
contains some common misunderstandings of the fundamental
basis of the Gorlin equation. The original Gorlin equation was an
equation for the anatomic oriﬁce area. The contraction coefﬁcient
was introduced because DP was measured at the jet vena contracta.
To obtain effective oriﬁce area (EOA) from the Gorlin equation,
the contraction coefﬁcient must not be used.
Fifth, the use of stroke volume and mean DP is incorrect (8).
In the range of EOA values that have been studied in this report,
there might be a  0.15-cm2 variation in the EOA, which could
confound diagnosis, particularly in the case of the PLG AS. It is
important to appreciate that the mean and root mean square DP
are not equal, and this is unfortunately often ignored erroneously
for convenience.
The authors must be commended for taking on a very difﬁcult
clinical problem; however, misunderstanding of the basis of these
derived metrics and patient selection muddy the waters further,
making clinical decisions challenging. We believe an integrated
approach combining rigorous clinical measurements and accurate
analysis is critical to thoroughly understand the clinical impact of
PLG AS.
Neelakantan Saikrishnan, PhD
*Ajit P. Yoganathan, PhD
Gautam Kumar, MD
*Wallace H. Coulter Department of Biomedical Engineering
Georgia Institute of Technology
387 Technology Circle NW
Atlanta, Georgia 30313
E-mail: ajit.yoganathan@bme.gatech.edu
http://dx.doi.org/10.1016/j.jacc.2013.06.058REFERENCES
1. Lauten J, Rost C, Breithardt OA, et al. Invasive hemodynamic
characteristics of low gradient severe aortic stenosis despite preserved
ejection fraction. J Am Coll Cardiol 2013;61:1799–808.2. Levine RA, Jimoh A, Cape EG, McMillan S, Yoganathan AP,
Weyman AE. Pressure recovery distal to a stenosis: potential cause of
gradient “overestimation” by Doppler echocardiography. J Am Coll
Cardiol 1989;13:706–15.
3. Voelker W, Reul H, Stelzer T, Schmidt A, Karsch KR. Pressure
recovery in aortic stenosis: an in vitro study in a pulsatile ﬂow model.
J Am Coll Cardiol 1992;20:1585–93.
4. Garcia D, Dumesnil JG, Durand L-G, Kadem L, Pibarot P. Discrep-
ancies between catheter and Doppler estimates of valve effective oriﬁce
area can be predicted from the pressure recovery phenomenon. J Am
Coll Cardiol 2003;41:435–42.
5. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-ﬂow,
low-gradient severe aortic stenosis despite preserved ejection fraction is
associated with higher afterload and reduced survival. Circulation 2007;
115:2856–64.
6. Lancellotti P, Magne J, Donal E, et al. Clinical outcome in asymp-
tomatic severe aortic stenosis. J Am Coll Cardiol 2012;59:235–43.
7. Jander N, Minners J, Neumann F-J, et al. Outcome of patients with
low-gradient “severe” aortic stenosis and preserved ejection fraction.
Circulation 2011;123:887–95.
8. Saikrishnan N, Yap CH, Lerakis S, Kumar G, Yoganathan AP.
Revisiting the Gorlin equation for aortic stenosisdis it correctly used in
clinical practice? Int J Cardiol 2013;168:2881–3.ReplyDiagnosis of “Paradoxical” Low-Gradient
Aortic Stenosis PatientsWe thank Dr. Saikrishnan and colleagues for their interest in and
attention to our paper (1) and are pleased that they ﬁnd that it
“deﬁnitely improves our understanding of this problem” (i.e.,
“paradoxic” low-gradient aortic stenosis). They raise several issues
that we would like to brieﬂy address.
 Cardiac catheterization as a gold standard. Nowhere do we
cite catheterization as gold standard in this paper, and we
discuss in detail limitations of the Gorlin formula. However,
as clinicians, we recognize that catheterization continues to
be the most widely used reference standard in cases echo-
cardiography is considered doubtful. It is unclear how, as
Dr. Saikrishnan and colleagues propose, “a bench-top
in vitro study” would help in such cases.
 Differences between echo and catheterization pressure data
due to pressure recovery. We entirely agree that this is an
important issue and have thus included the energy loss index
as a measure of stenosis severity in our analysis.
 Degree of stenosis in the paradoxic and the conventionally
deﬁned aortic stenosis groups. As we stated in our discus-
sion: “...overall there was a higher degree of obstruction, in
accordance with lower valve areas, higher gradients, and
lower energy loss index in this group (the high-gradient
aortic stenosis group) than in the ‘paradoxic’ aortic
stenosis group” (1). However, it should be remembered that
the original clinical question motivating this study was
whether “paradoxic” aortic stenosis is really severe at all. The
ﬁnding that patients with paradoxic aortic stenosis in our
study had mildly less obstruction than high-gradient aortic
stenosis does not necessarily predict that the patients with
paradoxic aortic stenosis have a more benign variant of
aortic stenosis.
